Transactions
33
Insider / Akouos, Inc.
Novartis Bioventures Ltd
Insider at Akouos, Inc.
- Company
- Akouos, Inc.
- First filing on record
- April 29, 2019
- Latest trade on record
- June 30, 2020
- SEC filings
- EDGAR ↗
Novartis Bioventures Ltd, Insider at Akouos, Inc., has disclosed 33 transactions in AKUS, GRTX, BCYC and 1 more since April 29, 2019: 3 purchases (3 open-market buys) and 16 sales, worth about $17.2M at the reported prices. The latest was filed July 2, 2020, 2 days after the trade.
Open-market buys
3
Sales
16
Avg. disclosure lag
1.6d
Trading in charts
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Novartis Bioventures Ltd has traded 4 stocks on record; the largest by dollars is GRTX.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 9 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 16 | 1,776,906 | $9.7M |
| C | Conversion of a derivative | 12 | 25,116,314 | — |
| P | Open-market purchase | 3 | 543,630 | $7.5M |
| X | Exercise of an in-the-money option | 2 | 142,900 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2020 | 19 | 1 · $2.1M | 14 · $9.0M |
| 2019 | 14 | 2 · $5.4M | 2 · $723K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| AKUS | Exchange C | June 30, 2020 | July 2, 2020 | 2d | 199,996 | — | — | indirectderivative | Form 4 ↗ | |
| AKUS | Exchange C | June 30, 2020 | July 2, 2020 | 2d | 856,262 | — | — | indirectderivative | Form 4 ↗ | |
| AKUS | Buy P | June 30, 2020 | July 2, 2020 | 2d | 125,000 | $17 | $2.1M | indirect | Form 4 ↗ | |
| AKUS | Exchange C | June 30, 2020 | July 2, 2020 | 2d | 199,996 | — | — | indirect | Form 4 ↗ | |
| AKUS | Exchange C | June 30, 2020 | July 2, 2020 | 2d | 856,262 | — | — | indirect | Form 4 ↗ | |
| GRTX | Sell S | June 19, 2020 | June 22, 2020 | 3d | 1,001,312 | $8 | $8.3M | Form 4 ↗ | ||
| GRTX | Sell S | June 18, 2020 | June 22, 2020 | 4d | 900 | $9 | $8,136 | Form 4 ↗ | ||
| GRTX | Sell S | June 17, 2020 | June 17, 2020 | 0d | 4,622 | $9 | $43K | Form 4 ↗ | ||
| GRTX | Sell S | June 16, 2020 | June 17, 2020 | 1d | 8,600 | $9 | $80K | Form 4 ↗ | ||
| GRTX | Sell S | June 15, 2020 | June 17, 2020 | 2d | 6,164 | $9 | $56K | Form 4 ↗ | ||
| GRTX | Sell S | June 12, 2020 | June 12, 2020 | 0d | 1,500 | $9 | $14K | Form 4 ↗ | ||
| GRTX | Sell S | June 11, 2020 | June 12, 2020 | 1d | 7,200 | $9 | $66K | Form 4 ↗ | ||
| GRTX | Sell S | June 10, 2020 | June 12, 2020 | 2d | 8,532 | $9 | $81K | Form 4 ↗ | ||
| GRTX | Sell S | June 9, 2020 | June 9, 2020 | 0d | 7,000 | $9 | $66K | Form 4 ↗ | ||
| GRTX | Sell S | June 8, 2020 | June 9, 2020 | 1d | 5,659 | $10 | $55K | Form 4 ↗ | ||
| GRTX | Sell S | June 5, 2020 | June 9, 2020 | 4d | 8,652 | $10 | $84K | Form 4 ↗ | ||
| GRTX | Sell S | June 4, 2020 | June 4, 2020 | 0d | 4,088 | $10 | $39K | Form 4 ↗ | ||
| GRTX | Sell S | June 3, 2020 | June 4, 2020 | 1d | 5,208 | $10 | $51K | Form 4 ↗ | ||
| GRTX | Sell S | June 2, 2020 | June 4, 2020 | 2d | 5,669 | $10 | $55K | Form 4 ↗ | ||
| GRTX | Exchange C | November 12, 2019 | November 12, 2019 | 0d | 451,609 | — | — | indirectderivative | Form 4 ↗ | |
| GRTX | Exchange C | November 12, 2019 | November 12, 2019 | 0d | 7,200,000 | — | — | indirectderivative | Form 4 ↗ | |
| GRTX | Exchange C | November 12, 2019 | November 12, 2019 | 0d | 9,000,000 | — | — | indirectderivative | Form 4 ↗ | |
| GRTX | Buy P | November 12, 2019 | November 12, 2019 | 0d | 250,000 | $12 | $3.0M | indirect | Form 4 ↗ | |
| GRTX | Exchange C | November 12, 2019 | November 12, 2019 | 0d | 3,293,067 | — | — | indirect | Form 4 ↗ | |
| BCYC | Exchange C | May 28, 2019 | May 30, 2019 | 2d | 636,366 | — | — | derivative | Form 4 ↗ | |
| BCYC | Option / conversion X | May 28, 2019 | May 30, 2019 | 2d | 71,450 | — | — | derivative | Form 4 ↗ | |
| BCYC | Exchange C | May 28, 2019 | May 30, 2019 | 2d | 893,195 | — | — | derivative | Form 4 ↗ | |
| BCYC | Buy P | May 28, 2019 | May 30, 2019 | 2d | 168,630 | $14 | $2.4M | Form 4 ↗ | ||
| BCYC | Exchange C | May 28, 2019 | May 30, 2019 | 2d | 636,366 | — | — | Form 4 ↗ | ||
| BCYC | Option / conversion X | May 28, 2019 | May 30, 2019 | 2d | 71,450 | — | — | Form 4 ↗ | ||
| BCYC | Exchange C | May 28, 2019 | May 30, 2019 | 2d | 893,195 | — | — | Form 4 ↗ | ||
| ARPO | Sell S | April 26, 2019 | April 29, 2019 | 3d | 138,704 | $1 | $143K | indirect | Form 4 ↗ | |
| ARPO | Sell S | April 25, 2019 | April 29, 2019 | 4d | 563,096 | $1 | $580K | indirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 2, 2020 | Form 4 | 0001104659-20-080559 | 5 | published | EDGAR ↗ |
| June 22, 2020 | Form 4 | 0000925421-20-000256 | 2 | published | EDGAR ↗ |
| June 17, 2020 | Form 4 | 0000925421-20-000254 | 3 | published | EDGAR ↗ |
| June 12, 2020 | Form 4 | 0000925421-20-000248 | 3 | published | EDGAR ↗ |
| June 9, 2020 | Form 4 | 0000925421-20-000244 | 3 | published | EDGAR ↗ |
| June 4, 2020 | Form 4 | 0000925421-20-000228 | 3 | published | EDGAR ↗ |
| November 12, 2019 | Form 4 | 0000899243-19-027115 | 5 | published | EDGAR ↗ |
| May 30, 2019 | Form 4 | 0001104659-19-032920 | 7 | published | EDGAR ↗ |
| April 29, 2019 | Form 4 | 0000925421-19-000179 | 2 | published | EDGAR ↗ |
Other insiders at Akouos, Inc.
- GLAXOSMITHKLINE PLC Insider 33 rows
- Thompson Travis Alvin Chief Financial Officer 14 rows
- Hannay Michael Charles Ferguson CHIEF PROD & SUPPLY CHAIN OFF 13 rows
- Skynner Michael CHIEF SCIENTIFIC OFFICER 13 rows
- Lee Kevin CHIEF EXECUTIVE OFFICER 12 rows
- Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer 10 rows
- Perry Jennifer Scott Chief Operating Officer 10 rows
- Young Alethia Chief Financial Officer 7 rows
- Milnes Alistair CHIEF OPERATING OFFICER 6 rows
- BAKER BROS. ADVISORS LP Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: Akouos, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 9 | 33 | April 29, 2019 | July 2, 2020 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.